1. Home
  2. ABR vs IMCR Comparison

ABR vs IMCR Comparison

Compare ABR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.08

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.52

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
IMCR
Founded
2003
2008
Country
United States
United Kingdom
Employees
653
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ABR
IMCR
Price
$5.08
$33.52
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$9.90
$66.33
AVG Volume (30 Days)
3.6M
626.4K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
30.39
EPS
N/A
0.25
Revenue
N/A
$249,428,000.00
Revenue This Year
N/A
$14.57
Revenue Next Year
N/A
$8.21
P/E Ratio
$9.29
$135.08
Revenue Growth
N/A
43.05
52 Week Low
$4.86
$27.56
52 Week High
$12.58
$40.71

Technical Indicators

Market Signals
Indicator
ABR
IMCR
Relative Strength Index (RSI) 44.98 53.57
Support Level $4.99 $30.84
Resistance Level $5.43 $34.09
Average True Range (ATR) 0.15 1.54
MACD 0.03 -0.13
Stochastic Oscillator 41.18 53.43

Price Performance

Historical Comparison
ABR
IMCR

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: